• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Thursday, August 28, 2025
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Health

More people in recovery from substance use problems are quitting smoking than ever before

Bioengineer by Bioengineer
January 23, 2019
in Health
Reading Time: 3 mins read
0
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

Study finds those who entered recovery from 2006 to 2015 quit smoking sooner than those entering recovery 20 years earlier

Smoking rates among people recovering from an alcohol or drug disorder are more than double that of the general population. But a study from the Massachusetts General Hospital (MGH) Recovery Research Institute), that will appear in the February issue of Drug and Alcohol Dependence and was published online last month, found that those entering recovery in the past 10 years are quitting in greater numbers than their cohorts in the 1980s and 90s.

“Smoking cessation is a well-known challenge among people in recovery from alcohol and drug use disorders, but very little was known previously about smoking prevalence in this population or when after entering recovery people were able to quit smoking,” says lead author John F. Kelly, PhD, founder and director of the Recovery Research Institute (RRI). “Our findings suggest more recovering people are quitting cigarettes and quitting sooner.”

While smoking is a major cause of premature death among individuals with a history of alcohol or drug use, there was scarce data on how many people quit before or after treatment and after entering recovery. The study by the RRI looked at smoking cessation in a national sample of people in recovery from problems with alcohol or other drugs.

Of 2,000 study participants who had entered recovery during each of three decade-long time frames from 1986 through 2015, more than half were former smokers and almost 30 percent were current smokers. While those who had stopped smoking did so an average of 15 years after resolving a drug or alcohol problem, those entering recovery from 2006 to 2015 successfully quit sooner after entering recovery than did those who had resolved their alcohol or drug issue between 1986 and 1995.

Among individuals in recovery with a smoking history, the study reported that 30 percent had quit smoking prior to entering recovery, 7 percent quit and entered recovery within the same year, and 26 percent quit after entering recovery. The 27 percent who were still smoking had tried unsuccessfully to quit an average of five times and were smoking an average of 14 cigarettes per day. Education and income seemed to play a role in successful quitting. Individuals who earned $50,000 or more and those who had a bachelor’s degree or higher quit sooner after entering recovery than others.

“This study provides good news: a historically vulnerable and hard-to-reach population of smokers appears to be quitting sooner following the resolution of an alcohol or other drug disorder than in prior years,” says Kelly, the Elizabeth R. Spallin Associate Professor of Psychiatry in the Field of Addiction Medicine at Harvard Medical School

###

Additional co-authors of the study are Brandon Bergman, PhD, associate director of the Recovery Research Institute, Bettina Hoeppner, PhD, of the RRI, and Claire Greene, PhD, Johns Hopkins Bloomberg School of Public Health. This research was supported by the Recovery Research Institute at the Massachusetts General Hospital and the National Institute on Alcohol Abuse and Alcoholism.

Massachusetts General Hospital, founded in 1811, is the original and largest teaching hospital of Harvard Medical School. The MGH Research Institute conducts the largest hospital-based research program in the nation, with an annual research budget of more than $900 million and major research centers in HIV/AIDS, cardiovascular research, cancer, computational and integrative biology, cutaneous biology, genomic medicine, medical imaging, neurodegenerative disorders, regenerative medicine, reproductive biology, systems biology, photomedicine and transplantation biology. The MGH topped the 2015 Nature Index list of health care organizations publishing in leading scientific journals and earned the prestigious 2015 Foster G. McGaw Prize for Excellence in Community Service. In August 2018 the MGH was once again named to the Honor Roll in the U.S. News & World Report list of “America’s Best Hospitals.”

Media Contact
Deborah Halber
[email protected]
617-643-4695
http://dx.doi.org/10.1016/j.drugalcdep.2018.11.017

Tags: AddictionAlcoholDrugsSmoking/TobaccoSocial/Behavioral Science
Share12Tweet7Share2ShareShareShare1

Related Posts

Dimethyl Sulfoxide in Mesenchymal Stem Cell Therapy: Risks?

August 28, 2025

Optimal Cannula Design for Venovenous ECMO Oxygenation

August 28, 2025

Ethics and Regulations in Multinational Genetic Studies

August 28, 2025

Baricitinib Safety in High-Risk Populations: Analysis Findings

August 28, 2025
Please login to join discussion

POPULAR NEWS

  • blank

    Breakthrough in Computer Hardware Advances Solves Complex Optimization Challenges

    149 shares
    Share 60 Tweet 37
  • Molecules in Focus: Capturing the Timeless Dance of Particles

    142 shares
    Share 57 Tweet 36
  • New Drug Formulation Transforms Intravenous Treatments into Rapid Injections

    115 shares
    Share 46 Tweet 29
  • Neuropsychiatric Risks Linked to COVID-19 Revealed

    82 shares
    Share 33 Tweet 21

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Dimethyl Sulfoxide in Mesenchymal Stem Cell Therapy: Risks?

Optimal Cannula Design for Venovenous ECMO Oxygenation

Ethics and Regulations in Multinational Genetic Studies

  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.